期刊文献+

八种抗精神病药物治疗女性精神分裂症患者的疗效及不良反应分析 被引量:23

Effectiveness and adverse reactions of eight kinds of antipsychotics in the treatment of female patients with schizophrenia
下载PDF
导出
摘要 目的观察八种抗精神病药对女性精神分裂症患者的疗效及不良反应。方法共纳入685例女性精神分裂症患者,分别接受奥氮平(10~30 mg/天)、喹硫平(500~750 mg/天)、利培酮(2~5.5 mg/天)、阿立哌唑(15~30 mg/天)、氟哌啶醇(10~30 mg/天)、氯氮平(150~450 mg/天)、舒必利(0.6~1.2/天)、齐拉西酮(80~160 mg/天)治疗,观察疗效和不良反应。结果八种抗精神病药对女性精神分裂症患者的疗效无显著性差异,对女性患者代谢的影响从大到小依次为氯氮平、奥氮平、喹硫平、氟哌啶醇、利培酮、齐拉西酮、舒必利、阿立哌唑;对女性患者内分泌影响最明显的是利培酮和舒必利;药源性焦虑以利培酮出现的比率最高;导致女性患者排尿困难最常见于阿立哌唑。结论应根据患者的不同年龄、对药物的疗效及不良反应出现的个体差异,做到用药个体化。 Objective To observe antipsychotic efficacy and adverse reactions of eight kinds of drugs to female patients with schizophrenia. Methods Participants included 685 female patients with schizophrenia,accepted olanzapine( 10 ~ 30 mg /day),quetiapine( 500~ 750 mg /day),risperidone( 2 ~5. 5 mg /day),aripiprazole azole( 15 ~ 30 mg /day),haloperidol( 10 to 30 mg /day),clozapine( 150 ~450 mg /day),sulpiride( 0. 6 ~ 1. 2 /day),and ziprasidone( 80 ~160 mg/day) respectively,and curative effect and adverse reactions were observed. Results The effects of eight antipsychotic drugs in female schizophrenic patients had no significant difference. The effect on metabolism from large to small were as clozapine,olanzapine,quetiapine,haloperidol,risperidone,ziprasidone,sulpiride,aripiprazole; And risperidone and sulpiride had the most obvious effect on endocrine,while the highest rate of drug-induced anxiety appeared in which with risperidone,and dysuria was the most common in which with aripiprazole. Conclusion Individualized medication should be adopted according to the age,individual differences of effectiveness and adverse reactions in female patients with schizophrenia.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2014年第4期305-309,313,共6页 Journal of Harbin Medical University
基金 黑龙江省卫生厅课题(2007-282)
关键词 抗精神病药 精神分裂症 女性 疗效 不良反应 antipsychotic drugs schizophrenia women curative effect adverse reactions
  • 相关文献

参考文献18

  • 1Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizo- phrenia: a critical review of pharmacology and mechanisms of ac- tion of antipsychotic drugs[ J]. Mol Psychiatry, 2005,10( 1 ) :79- 104.
  • 2Rosenheck R, Perlick D, Bingham S, et al. Effectiveness and eost of olanzapine and haloperidol in the treatment of schizophreni- a: a randomized controlled trial [ J ]. JAMA, 2003,290 (20) : 2693 -2702.
  • 3Tollefson GD, Sanger TM. Negative symptoms : a path analytic ap- proach to a double-blind, placebo- and haloperidol-eontrolled clin- ical trial with olanzapine [ J ]. Am J Psychiatry, 1997,154 ( 4 ) : 466 -474.
  • 4Keefe RS, Silva SG, Perkins DO, et al. The effects of atypical antipsyehotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis [ J ]. Schizophr Bull, 1999,25 ( 2 ) : 201-222.
  • 5Tollefson GD, Sanger TM, Lu Y, et al. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanza- pine and haloperidol [ J ]. Arch Gen Psychiatry, 1998,55 ( 3 ) : 250-258.
  • 6Allison DB, Mentore JL, Heo M, et al. Antipsyehotic-induced weight gain : a comprehensive research synthesis [ J ]. Am J Psy- chiatry, 1999,156 ( 11 ) : 1686-1696.
  • 7Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabo- lism in patients with schizophrenia treated with atypical antipsy- chotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis[J]. Arch Gen Psychiatry, 2005, 62(1) :19-28.
  • 8Koro CE, Fedder DO, L'halien GJ, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients [ J ]. Arch Gen Psychiatry, 2002,59 ( 11 ) : 1021-1026.
  • 9Wahlbeck K, Tuunainen A, Ahokas A, et al. Dropout rates in randomised antipsychotic drug trials [ J ]. Psychopharmacology (Bed), 2001,155(3) :230-233.
  • 10林涌超,欧文前,李凌恩,张茹.氨磺必利与氯氮平对阴性症状为主的精神分裂症患者临床疗效及生活质量的对照研究[J].中华行为医学与脑科学杂志,2012,21(8):705-708. 被引量:76

二级参考文献78

共引文献149

同被引文献188

引证文献23

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部